• Download mobile app
17 Nov 2026, Edition - 4144, Tuesday

Trending Now

  • “Why has no action been taken in the matters involving Deputy Speaker Ravishankar and Kallakurichi MLA Arul Vignesh?” – NTK coordinator Seeman
  • “Is Epstein a victim? Is Gem Veeramani a victim? Is there no protection even for the Collector? What is the TVK Govt trying to cover up?” – Selvaperunthagai
  • “My phone contains evidence regarding the PM’s foreign connections. PM Modi is tapping my phone because I have this evidence.” – Alleged Rahul Gandhi
  • “The Karnataka CM has once again started speaking strongly about constructing the Mekedatu dam. The TN Govt should not remain silent any longer.” – M.K.Stalin

Businesswire

Taro Announces Completion of $250 Million Share Repurchase Program

by businesswireindia.com

Share
Business Wire India

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced that it has completed its $250 million share repurchase program. The company bought back 2,493,378 of its ordinary shares in open market transactions at an average price of $100.28 per share. The repurchase program was announced by the company on November 23, 2016, and was completed on January 11, 2019.

 

About Taro

 

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

 

 

 

 
Source: Businesswire
COIMBATORE WEATHER